[{"Assets_0_Q1_USD":13979400000.0,"CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q1_USD":0.16,"CommonStockSharesConverted_0_Q1_shares":143400000.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":0.5,"EarningsPerShareDiluted_1_Q1_USD":0.5,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":194500000.0,"NetIncomeLossConverted_1_Q1_USD":71600000.0,"OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q1_USD":1194000000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":6067300000.0,"StockholdersEquity_0_Q1_USD":6067800000.0,"Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":143600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":143400000.0,"filed":"20170530","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2017.0","name":"PERRIGO CO PLC","period":"20170331","qtrs":"0","uom":"USD"}]